10x Genomics, Inc.

10x Genomics: The Turnaround Is Real, But Atera Now Has To Deliver (Rating Upgrade)

Markets 35 d ago

10x Genomics (TXG) Sees Strong Early Orders for New Atera Platform

Markets 37 d ago

Earnings call transcript: 10x Genomics lifts 2026 outlook on strong Atera demand in Q2 2026

Earnings 48 d ago 2 sources

10x genomics director Stuelpnagel sells $1.2 million in shares

Markets 15 d ago 3 sources

10x Genomics CEO Serge Saxonov sells $667,900 in stock

Markets 26 d ago

10x Genomics director John Stuelpnagel sells $1.15m in shares

Markets 41 d ago 2 sources